Hyundai ADM Bio said Monday that it is working on a new drug, Penetrium, which is intended to help enhance the efficiency of ...

DynaCAD urology with advanced annotation UroNav cart with advanced annotation option UroNav with advanced annotation July 23, 2025 Supporting prostate cancer diagnosis with more precise guidance for ...

A stage-four cancer diagnosis once sounded like the end of the road – after all, there is no stage five. When Joe Biden’s ...

AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body's vascular system, expanding cancer treatment options ...

Finding cancer early makes it much more likely that treatment will work. There are early signs of cancer that are easy to ...

Research confirms that many men with nonmetastatic prostate cancer will not die of their disease once they received recommended treatment.

Prostate cancer is one of the most common cancers in men in the United States. While one in nine men will be diagnosed with ...

Medical specialists often order a multiparametric MRI (mpMRI) following elevated PSA levels to determine if biopsies are ...

Cubs legend and Baseball Hall of Fame member Ryne Sandberg provided an update on health Wednesday morning in a statement ...

Carotuximab plus Erleada proved safe in the first 10 patients with metastatic castration-resistant prostate cancer dosed on the phase 2 trial.

A phase 2 trial shows promising safety results for carotuximab in treating advanced prostate cancer, offering hope for ...

The ARANOTE trial (NCT04736199) represents a significant step forward in the treatment landscape for patients with metastatic ...